 |
From whole-genome sequencing to gene expression regulation: Perspectives for improving oncological outcomes. |
|
|
|
1-6 |
|
|
Whole-genome sequence: from research to clinical practice? |
|
|
|
7-12 |
|
|
Inhibiting mTOR and VEGF signaling in pancreatic neuroendocrine tumors |
|
|
|
13-19 |
|
|
Gastric cancer recurrence: Is it influenced by laparoscopic gastrectomy? |
|
|
|
20-22 |
|
|
Laparoscopic Sentinel Node Biopsy in Solid Cancer |
|
|
|
23-25 |
|
|
From Asia to Europe: Laparoscopic and robotic gastrectomy for cancer |
|
|
|
26-28 |
|
|
The up and down of KRAS testing for personalized colorectal cancer treatment
|
|
|
|
29-31 |
|
|
Monitoring EGFR plasma levels: Is it a biomarker for colorectal cancer? |
|
|
|
32-34 |
|
|
Pancreatic adenocarcinoma: a grand challenge |
|
|
|
35-37 |
|
|
|
|
|
|
38-40 |
|
|
Economic crisis and laparoscopic surgery |
|
|
|
41-43 |
|
|
New standard targeted therapy for pancreatic neuroendocrine tumors |
|
|
|
44-49 |
|
